Search

everythinglearnresearchcommunity

for

Search:↓

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Spironolactone treatment increases the amount of testosterone available in the body.

Testosterone therapy increases bone density in older men with low testosterone levels.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

The risks of testosterone implants in women outweigh the benefits.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.